| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Bankruptcy > Alternatives To Filing For Bankruptcy |
|
Advice You - Alternatives To Filing For Bankruptcy
Though it sounds like an easy and attractive solution for one's financial problems, bankrup According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product tcy should be the last option any individual should resort to. It can cause enormous damage ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in , not only to the individual's credit report, but also to his or her social standing and re lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. utation. There are quite a few alternatives to filing for bankruptcy. Negotiating with th here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e creditors is one of the alternatives. Creditors know that the reason an individual files d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro or bankruptcy is due to his or her inability to pay off excessive debt. Instead of risking ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc losing everything in a bankruptcy case, most creditors would be more than willing to negoti easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ate in order to recover at least a portion of what the individual owes them. Another advan nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically age of negotiation is that it will also buy the individual some time to allow him to rebuil and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ d his finances. Debt consolidation is another alternative. This method consists of the deb ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi or borrowing one low interest loan from a lender, typically a bank, to pay off other high i ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a nterest debts like credit cards, for example. This allows him to replace multiple high inte dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod rest loans with a single low interest loan. This makes the debt easier to repay since the d cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin btor only has to make one payment. Also, since the loan is a low interest one, it is poss tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ible for the debtor to pay it back faster by applying more of his monthly payment against t t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e principal of the loan. The best alternative by far is smart money management. The reason ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust people fall into debt is because they spend more than they earn. The most logical solution y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products would be to reduce monthly expenditure to set aside more money to pay off one?s debts. Bud . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de eting your money and constantly finding ways, sometimes innovative ones, to reduce your mon elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip thly expenses is the best way to repay all your debts without having to file for bankruptcy tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Why Starting A Daycare Is The Best Thing Since Sliced Bread Case Study; Television Infomercials Are They Viable? Negotiating: Collaboration A Win-Win Strategy
|